The Zacks Computer-Peripheral Equipment industry players like LG Display (LPL) , Immersion (IMMR) and TransAct Technologies (TACT) are well-poised to benefit from the growing demand for professional gaming accessories, touchscreen and wireless devices, smart glasses and RFID (Radio Frequency Identification) solutions. A continuously improving shipment of personal computers (PCs) bodes well for PC peripheral market prospects. Moreover, the solid demand for 3D-printed health equipment like face shields, nasal ...

SHANGHAI, July 7, 2025 /PRNewswire/ -- Eshallgo Inc. (Nasdaq: EHGO), a leading provider of integrated office solutions in China, today announced that its wholly owned subsidiary, Shanghai ESHALLGO Enterprise Development (Group) Co., Ltd. ("ESHALLGO Group"), has entered into a nationwide strategic partnership agreement (the "Agreement") with Tianjin Photonetco Electronic Technology Co., Ltd. ("Photonetco"), one of China's top three office equipment manufacturers.The Agreement appoints EHGO as Photonetco's ex ...

Financial Status and Strategy - CureVac has a strong financial position with €550.9 million in cash as of September 30, 2024, and an expected cash runway into 2028[82, 87] - The company streamlined costs and enhanced financial discipline, including a 30% workforce reduction expected by the end of 2024[8, 85, 88] - CureVac refocused its portfolio on innovation and R&D, concentrating on high-value programs in infectious diseases and oncology[8, 9] - A strategic transformation is on track, with OPEX expected to decrease by over 30% from 2025 onwards, including a €25 million decrease in personnel costs[85] Pipeline and Development - CureVac is advancing key pipeline milestones for novel medicines targeting unmet needs, with a focus on expanding the pipeline in oncology and infectious diseases[10, 14] - In oncology, a new shared-antigen lung cancer program is set to start clinical trials in H2 2025, and personalized cancer vaccines are progressing with the first candidate expected to enter the clinic in H2 2026[14] - For infectious diseases, a new non-respiratory program was initiated for Uropathogenic E coli (UPEC) in urinary tract infections, with promising preclinical data[14] - Respiratory infectious disease programs, including seasonal influenza, avian influenza, and COVID-19, are fully out-licensed to GSK, with Phase 3 starting for seasonal flu in 2025[13, 37, 86] Technology and Manufacturing - CureVac's mRNA platform is versatile, featuring precision mRNA backbone, improved LNP delivery systems, and a strong intellectual property portfolio[12, 13] - The company utilizes advanced delivery systems, including proprietary therapeutic area-specific next-generation lipid nanoparticles, and scalable manufacturing, including The RNA Printer®[12] - CureVac's Infectious Disease LNP offers thermostability for more than 12 months at refrigerator temperature (2-8°C)[60]

12th Anniversary of SkillsUSA Additive Manufacturing Competition SOUTHFIELD, Mich., June 30, 2025 (GLOBE NEWSWIRE) -- SME, the nonprofit committed to building and expanding North America's talent and capabilities and accelerating advanced manufacturing technologies, and global additive manufacturing leader Stratasys, announced the winners of their cosponsored 2025 Additive Manufacturing Competition, conducted as part of the 61th annual SkillsUSA National Leadership and Skills Conference, held in Atlanta Jun ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Za ...

Singapore, June 17, 2025 (GLOBE NEWSWIRE) -- Concorde International Group Ltd. (NASDAQ: CIGL) (“Concorde” or the “Company”), an integrated security services provider that combines physical manpower and innovative technology to deliver effective security solutions, today announced that it has secured a total of SG$11,621,370 (approximately US$9,040,472) in new contracts from January through May 2025. The contracts include engagements with new clients as well as expanded agreements with existing customers acr ...

Core Insights - The celebrity entrepreneurship boom is cooling down, but top female stars in the film, television, and music industries continue to generate significant income despite economic downturns [2] - The threshold for inclusion in Forbes' list of America's richest self-made women has increased, with the minimum net worth rising from $300 million last year to $350 million this year [3] Group 1: Wealth Trends - Sixteen celebrities made it to the Forbes list, with a total wealth of $14.1 billion, up from $13.3 billion last year, largely due to Selena Gomez's new entry with a net worth of approximately $700 million [3] - The beauty market is experiencing a downturn, impacting the wealth of several female celebrities, including Rihanna, whose net worth decreased by nearly 30% due to poor sales performance of her beauty brand [5][10] Group 2: Business Ventures - Selena Gomez launched her beauty brand Rare Beauty in September 2020, which reported revenues of $367 million by 2023 [4] - Rihanna's lingerie brand Savage x Fenty was valued at $1 billion in early 2021, but has faced challenges, including the departure of its CEO [4][10] - Reese Witherspoon's production company Hello Sunshine was sold for an estimated $900 million, but its current valuation is projected to be less than one-third of that amount by 2025 [5][26] Group 3: Individual Celebrity Performance - Taylor Swift's wealth increased by $300 million to $1.6 billion, driven by her record-breaking Eras Tour, which grossed over $2 billion [6][13] - Kim Kardashian's net worth remains stable at $1.7 billion, with her shapewear brand Skims launching a collaboration with Nike [10] - Judy Sheindlin's wealth grew by 4% to $580 million, thanks to her ongoing successful television program [20]

Acacia Research (ACTG) FY Conference Summary Company Overview - Acacia Research has transitioned from an intellectual property business to a value-based acquirer of companies, focusing on creating a diversified portfolio of assets [2][3] - The company has a book value of approximately $577 million, translating to about $6 per share, with $340 million in cash and public securities [4] Financial Performance - Acacia generated $222 million in revenue and $61 million in EBITDA, with $40 million of EBITDA related to its former intellectual property business [5] - The company operates with no debt, emphasizing a strong financial position [5] Investment Strategy - The management team, led by the CEO with a private equity background, focuses on acquiring undervalued businesses, particularly in contrarian sectors [6][8] - Acacia aims to improve the operational efficiency and profitability of acquired businesses, emphasizing hands-on management rather than passive ownership [10][11] - The company has seen a significant number of acquisition opportunities, evaluating 350 businesses last year and 280 so far this year, but remains selective [9][50] Recent Acquisitions - Acacia has made strategic acquisitions, including Benchmark Energy and Deflecto, to build a scaled oil and gas platform and diversify its portfolio [15][22] - The acquisition of Benchmark was based on identifying dislocation in the oil and gas market, focusing on cash flow generation rather than traditional valuation metrics [17][19] - Deflecto was acquired as a collection of three unrelated businesses, with plans to streamline operations and enhance value through cost-cutting and management alignment [22][24] Operational Focus - The company emphasizes operational improvements and continuous enhancement of acquired businesses, aiming to generate cash flow and increase margins [11][20] - Acacia's approach includes leveraging existing management expertise and operational partners to drive performance in acquired companies [8][26] Market Position and Future Outlook - Acacia is exploring opportunities in specialty lending and insurance, indicating a strategic focus on markets with limited capital flow [51][52] - The company is cautious about entering new markets, preferring to build around existing positions and leverage its team's expertise [54] - Acacia aims to unlock trapped value in its portfolio, with a long-term vision of growing into a formidable public holding company with multiple large businesses [42][43] Conclusion - Acacia Research is positioned as a value-oriented acquirer with a strong financial foundation and a clear strategy for operational improvement and growth through selective acquisitions [34][55]

Brady (BRC) Conference June 11, 2025 02:30 PM ET Speaker0 Good afternoon, everyone, and welcome back to Sidoti's Virtual Investor Conference. I do see there's still some people filling into the room. But I'll take this time right now and just remind everyone if you have questions, we expect a few minutes after the informative presentation. You press that q and a button at the bottom of your screen, type in the questions, and we'll get to as many as we can, time permitting. So happy to welcome CFO Anne Thorn ...

Core Insights - AstroNova, Inc. reported a net loss of 5 cents per share for Q1 fiscal 2026, a decline from a net income of 15 cents per share in the same quarter last year [2] - The company's revenues increased by 14.4% year over year to $37.7 million, driven by growth in both the Product Identification and Aerospace segments [2] - Despite revenue growth, profitability metrics declined, with operating income dropping to $0.6 million from $1.3 million a year ago [3] Financial Performance - Adjusted net income for the quarter was 5 cents per share, down from 15 cents per share in the prior-year quarter [2] - Operating income for the Product ID segment decreased by 6.7% to $2.8 million, while adjusted operating income rose 4.4% to $3.1 million [4] - The Aerospace segment's operating income increased by 60.5% year over year to $2.8 million, with adjusted operating income at 25.7% of revenue [5] Orders and Backlog - Orders rose 5.4% year over year to $34.9 million, supported by growth in Product ID [6] - Backlog declined to $25.5 million from $28.3 million at the end of fiscal 2025, primarily due to fulfillment of previously delayed shipments [6] Management Commentary - CEO Greg Woods highlighted the transition to high-margin ToughWriter products and the commercialization of next-generation Product ID printers [7] - Management noted that 83% of revenue was recurring and attributed improved adjusted operating income to synergies from the MTEX acquisition [7] Cost Management and Guidance - AstroNova reaffirmed its full-year fiscal 2026 outlook, expecting revenue between $160 million and $165 million, indicating about 7% growth at the midpoint [12] - Adjusted EBITDA margin is projected to range from 8.5% to 9.5%, reflecting continued margin expansion from cost containment efforts [12] Other Developments - The integration of MTEX into the Product ID segment contributed $1.4 million in revenues [13] - The company executed $1.9 million in annualized cost reductions as part of a broader $3 million restructuring initiative [13] - AstroNova improved its liquidity position to $12.6 million and reported free cash flow of $4.4 million for the quarter [13]